In this episode of Covington's Life Sciences Podcast, Marie Doyle-Rossi, Anna Wawrzyniak, and Valeria Sturla discuss the position adopted by the European Parliament on 10 April 2024 on the Commission proposal to reform the core EU pharmaceutical legislation.

Parliament's position comes less than a year since the Commission published its proposal, and constitutes a significant step in the legislative process. Although many of the Parliament's amendments to the Commission proposal can be seen as improvements by the innovative industry, many challenges and some unresolved questions remain, especially in relation to the incentive regime.

During this audiocast, we therefore discuss improvements, challenges and unresolved questions of the EU Pharma law review, with a particular focus on incentives.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Covington & Burling LLP. Innehållet i podden är skapat av Covington & Burling LLP och inte av, eller tillsammans med, Poddtoppen.